In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates

被引：9
|
作者：
Prammananan, Therdsak [2 ,4 ]
Chaiprasert, Angkana [1 ,2 ]
Leechawengwongs, Manoon [2 ,3 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand
[2] Siriraj Fdn, Drug Resistant TB Res Fund, Bangkok 10700, Thailand
[3] Vichaiyut Hosp, Bangkok 10400, Thailand
[4] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani 12120, Thailand
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2009年 / 33卷 / 02期
关键词：
MYCOBACTERIUM-TUBERCULOSIS;
D O I：
10.1016/j.ijantimicag.2008.08.007
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：190 / 191
页数：3
相关论文
共 50 条
  • [21] In Vitro Activity of Linezolid against Clinical Isolates of Mycobacterium tuberculosis, including Multidrug-Resistant and Extensively Drug-Resistant Strains from Beijing, China
    Yang, Caie
    Lei, Hong
    Wang, Di
    Meng, Xianghong
    He, Jufang
    Tong, Aihua
    Zhu, Lei
    Jiang, Ying
    Dong, Mei
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2012, 65 (03) : 240 - 242
  • [22] New drug for multidrug-resistant (MDR) tuberculosis (TB)
    Arya, Vivek
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 253 - 253
  • [23] Extensively drug-resistant tuberculosis (XDR TB): Air travel exposure
    不详
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (04) : 288 - 288
  • [24] Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
    Cong Yao
    Haiping Guo
    Qiang Li
    Xuxia Zhang
    Yuanyuan Shang
    Tongxin Li
    Yufeng Wang
    Zhongtan Xue
    Lu Wang
    Liang Li
    Yu Pang
    Antimicrobial Resistance & Infection Control, 10
  • [25] Study prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Tuberculosis in East Azerbaijan province of Iran
    Mehdi, Roshdi Maleki
    Reza, Moaddab Seyyed
    Mohammad, Rahbar
    HEALTHMED, 2012, 6 (09): : 3091 - 3094
  • [26] Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition
    Yao, Cong
    Guo, Haiping
    Li, Qiang
    Zhang, Xuxia
    Shang, Yuanyuan
    Li, Tongxin
    Wang, Yufeng
    Xue, Zhongtan
    Wang, Lu
    Li, Liang
    Pang, Yu
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2021, 10 (01)
  • [27] Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
    Agyeman, Akosua Adom
    Ofori-Asenso, Richard
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2016, 15
  • [28] Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
    Mirsaeidi, SM
    Tabarsi, P
    Khoshnood, K
    Pooramiri, MV
    Rowhani-Rahbar, A
    Mansoori, SD
    Masjedi, H
    Zahirifard, S
    Mohammadi, F
    Farnia, P
    Masjedi, MR
    Velayati, AA
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (06) : 317 - 322
  • [29] Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China Comment
    Zhang, Peize
    Tan, Jie
    Lin, Yi
    Zhang, Hailin
    Deng, Guofang
    Chen, Xiaoyou
    DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (02): : 96 - 98
  • [30] Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
    Akosua Adom Agyeman
    Richard Ofori-Asenso
    Annals of Clinical Microbiology and Antimicrobials, 15
12345